{"id":1437,"date":"2020-02-13T13:12:38","date_gmt":"2020-02-13T18:12:38","guid":{"rendered":"http:\/\/blogs.uml.edu\/m2d2\/?p=1437"},"modified":"2020-02-18T11:19:16","modified_gmt":"2020-02-18T16:19:16","slug":"capcat-offering-100k-awards-for-point-of-care-tech","status":"publish","type":"post","link":"https:\/\/blogs.uml.edu\/m2d2\/2020\/02\/13\/capcat-offering-100k-awards-for-point-of-care-tech\/","title":{"rendered":"CAPCaT Offering $100K Grant Awards for Point-of-Care Tech"},"content":{"rendered":"\n<p>The Center for Advancing Point of Care Technologies (CAPCaT) is <a href=\"https:\/\/cimit.net\/web\/capcat\/solicitations\">actively searching for point-of-care technologies<\/a> that can be applied to heart, lung, blood or sleep disorders. Entrepreneurs (from anywhere in the world) whose inventions are approaching the clinical testing phase are encouraged to apply for point-of-care grant awards of up to $100,000. The Expression of Interest deadline is Monday, March 2 at 4:59 pm EST.<\/p>\n\n\n\n<!--more-->\n\n\n\n<p>Complementary and integrative health approaches within these disease areas are welcomed to apply.\u00a0 CAPCaT plans to fund up to six point-of-care grant awards of up to $100,000 over 12 months, with at least one award recognizing complementary or integrative health tech. <\/p>\n\n\n\n<p><a href=\"https:\/\/cimit.net\/web\/capcat\/solicitations\"><strong>Learn more about CAPCaT\u2019s point-of-care tech grant awards<\/strong><\/a><a href=\"https:\/\/cimit.net\/web\/capcat\/solicitations\"><strong>.<\/strong><\/a><\/p>\n\n\n\n<h2><strong>What is CAPCaT?<\/strong><\/h2>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"alignright is-resized\"><img loading=\"lazy\" src=\"https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/logo-01232020-1.png\" alt=\"CAPCaT is offering point-of-care grant awards for tech that addresses heart, lung, blood, and sleep disorders.\" class=\"wp-image-1439\" width=\"260\" height=\"196\" srcset=\"https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/logo-01232020-1.png 403w, https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/logo-01232020-1-300x227.png 300w, https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/logo-01232020-1-396x300.png 396w\" sizes=\"(max-width: 260px) 100vw, 260px\" \/><\/figure><\/div>\n\n\n\n<p>Based at UMass Medical\nSchool and UMass Lowell, CAPCaT was established with support from the National\nHeart, Lung, and Blood Institute (NHLBI) as well as the National Center for\nComplementary and Integrative Health (NCCIH). Their core mission is to support\ndevelopment, deployment, and testing of promising \u201clate-stage\u201d point of care\ntechnologies that can be rapidly deployed to enhance the diagnosis, monitoring,\nmanagement, and prevention of heart, lung, blood, or sleep disorders (NHLBI),\nwith an additional interest in projects that incorporate complementary and\nintegrative health approaches (NCCIH). <\/p>\n\n\n\n<p>CAPCaT is a member of the\nNIH Point of Care Technologies Research Network (POCTRN), which also includes\ncenters at John Hopkins University and Northwestern University, as well as an\nAtlanta center (ACME-POCT) that leverages resources at Emory University\u2019s hospitals,\nChildren\u2019s Healthcare of Atlanta, and Georgia Tech. <\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"alignleft is-resized\"><img loading=\"lazy\" src=\"https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/adult-biology-chemical-chemist-356040-1024x683.jpg\" alt=\"CAPCaT's point-of-care grant awards can be as high as $100,000 for advances in heart, lung, blood, and sleep disorders.\" class=\"wp-image-1440\" width=\"263\" height=\"175\" srcset=\"https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/adult-biology-chemical-chemist-356040-1024x683.jpg 1024w, https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/adult-biology-chemical-chemist-356040-300x200.jpg 300w, https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/adult-biology-chemical-chemist-356040-768x512.jpg 768w, https:\/\/blogs.uml.edu\/m2d2\/wp-content\/uploads\/sites\/46\/2020\/02\/adult-biology-chemical-chemist-356040-450x300.jpg 450w\" sizes=\"(max-width: 263px) 100vw, 263px\" \/><\/figure><\/div>\n\n\n\n<p>CAPCaT assists inventors developing new technologies and\nmedical devices designed to help patients with these conditions manage their\nwell-being wherever they are. The goal is to improve quality of life and reduce\nthe time patients spend in the hospital. <\/p>\n\n\n\n<h2><strong>CAPCaT\u2019s Connection to M2D2<\/strong><\/h2>\n\n\n\n<p>Supported by a $7.9 million grant from the NIH, CAPCaT is affiliated\nwith the Massachusetts Medical Device Development Center (M2D2), operated by\nUMass Lowell and UMass Medical School. M2D2 helps biotech and medical-device\nstartups bridge the gap between idea and market. CAPCaT is driven by the talent\nand aspirations of participating entrepreneurs; the expertise of scientists,\nbusiness developers and legal analysts; and the resources available at UMass\nLowell and UMass Medical School in collaboration with industry partners.<\/p>\n\n\n\n<p>M2D2\u2019s support of medical-device startups in Massachusetts\nhas contributed $42 million in direct economic impact with a total positive\neffect of $75 million, according to the UMass Donahue Institute. Expanding\nCAPCaT is expected to increase this impact.<\/p>\n\n\n\n<h3><a href=\"https:\/\/cimit.net\/web\/capcat\/solicitations\"><strong>Apply\nfor this $100K opportunity by March 2\u2014Details here.<\/strong><\/a><\/h3>\n","protected":false},"excerpt":{"rendered":"<p>The Center for Advancing Point of Care Technologies (CAPCaT) is actively searching for point-of-care technologies that can be applied to heart, lung, blood or sleep disorders. Entrepreneurs (from anywhere in the world) whose inventions are approaching the clinical testing phase &hellip; <a href=\"https:\/\/blogs.uml.edu\/m2d2\/2020\/02\/13\/capcat-offering-100k-awards-for-point-of-care-tech\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":328,"featured_media":1439,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/posts\/1437"}],"collection":[{"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/users\/328"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/comments?post=1437"}],"version-history":[{"count":7,"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/posts\/1437\/revisions"}],"predecessor-version":[{"id":1449,"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/posts\/1437\/revisions\/1449"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/media\/1439"}],"wp:attachment":[{"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/media?parent=1437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/categories?post=1437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.uml.edu\/m2d2\/wp-json\/wp\/v2\/tags?post=1437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}